For Investors

Pebble Labs’ Directed Biotics platform technology is able to rapidly address issues and emerging diseases that affect aquaculture and agriculture.

A key differentiator of Directed Biotics is the ability to engineer microbes that deliver RNAi in a novel and cost-effective method to fight viral pathogens without the use of chemicals and antibiotics.

Key Contacts:

Michael Harrison
Chairman of the Board

David Morgan
President and CEO

Edward Cheung
President Pebble Labs Asia Pacific

Rick DeRose, PhD, PMP
Vice President Product Development